What is Coroflo?
Coroflo is the developer of Coro, recognized as the world's first accurate breastfeeding monitor. This pioneering device offers real-time analytics on breast milk intake, providing mothers with crucial data on milk flow and volume. By enhancing the breastfeeding experience with evidence-based information, Coroflo aims to support new and expectant mothers in making informed decisions. The company's commitment to innovation has been acknowledged with accolades such as the Red Dot Award for Innovation 2025.
How much funding has Coroflo raised?
Coroflo has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2024): $3M, investors not publicly disclosed
What's next for Coroflo?
With the recent major strategic investment, Coroflo is poised for significant expansion and further product development. This capital infusion is expected to accelerate the company's go-to-market strategy, enhance its technological capabilities, and broaden its reach within the maternal health sector. The focus on enterprise-level funding suggests a strategic alignment with partners looking to scale innovative health-tech solutions, positioning Coroflo for substantial growth and market leadership.
See full Coroflo company page
